News

Scitara Corporation, a global provider of laboratory-specific, cloud-based software solutions for the biopharmaceutical and industrial markets, announced the closing of $5 million in a Series A round. The investment was led by Northpond Ventures, with participation from existing investor...

Takeda Pharmaceutical Company Limited ("Takeda") announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitalization, regardless of an individual's previous dengue exposure, with no important safety risks identified through three years after vaccination in...

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased new land as part of a $17 million investment into its Conshohocken, PA site. The new 4-acre plot is directly adjacent to...

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ is...

Kanishk Kala1 Rupinder Kaur Sodhi2 CCP Mohali IK Gujral PTU COVID-19 has become a global threat with immense mortality and morbidity in India.1The efforts of scientists are in line to give a concrete solution for the problem. The vaccine has...

Ashfield Engage, part of UDG Healthcare plc., announces the acquisition of Nuvera LLC, a US-based healthcare consulting firm specializing in patient support programs has complete. Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment...

India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, which could boost the country's overall supplies amid a shortage. "The infrastructure and plants are completely separate for both the products and we will be...